EORTC Quality of Life Group (QLG)

📌 #ESMO26 e-poster spotlight “Are we measuring the symptoms that matter most to patients? Our analysis shows existing @eortc.org questionnaires capture most common treatment-related symptoms in #HeadNeckCancer.” Congrats to @mkmoutafi.bsky.social et al. 👏 #GivingVoice2Patients @myesmo.bsky.social

Come and meet us at #ESMO26 at booth S1041, Hall 10 👋 Find out how to submit your research to #EORTCSummit, explore EORTC membership and discover all the opportunities to get involved in our clinical research. @myesmo.bsky.social

📍 We're in Madrid for #ESMO26! The EORTC team is at booth S1041 throughout the congress. If you're attending ESMO, stop by to meet the team and learn more about our research and collaborations. We'd love to see you there! 👋 #EORTC #CancerResearch @myesmo.bsky.social

📢 #ESMO26 Congress opens tomorrow in Madrid. Throughout the congress, EORTC researchers and collaborators will present multidisciplinary research across oral presentations, mini orals, posters, e-posters and trials in progress. 🔗 Explore our abstract overview: www.eortc.org/blog/2026/10...

📊 Also at #ISOQOL 2026, Niclas Hubel presented research on predicting fatigue & physical functioning in #BreastCancer. Using repeated measurements to incorporate time into HRQoL predictions may better reflect patient trajectories and support more personalised care. #GivingVoice2Patients @eortc.org

📢New questionnaires, interpretation guidelines, survivorship tools, paediatric #CancerResearch & initiatives to improve the use of patient-reported outcomes (PROs): discover key @eortc.org #QualityofLife Group research presented at #ISOQOL 2026. 🔗 www.eortc.org/blog/2026/10... #GivingVoice2Patients

📖 Yesterday afternoon at #ISOQOL, @msztankay.bsky.social presented the @eortc.org Patient-Reported Outcome Interpretation Guideline. The project also introduces new resources to help patients understand EORTC PRO data, coming soon on our EORTC #QualityofLife Group website. #GivingVoice2Patients

🏆 Congratulations to Galina Velikova on receiving the ISOQOL President's Award at #ISOQOL 2026! A pioneer in PROMs in clinical practice, former Chair of the @eortc.org #QualityofLife Group (QLG), and leader of numerous QLG projects. We are proud to see her honoured with this award. 👏

💡 Also this morning at #ISOQOL, @msztankay.bsky.social presented PROcoach, the new @eortc.org e-learning course designed to support the use of PROs in clinical practice. The course aims to help bring the patient perspective more effectively into oncology care. #GivingVoice2Patients #QualityofLife

🗣️ This morning at #ISOQOL 2026, Morten Petersen presented research showing that summary scores based on the @eortc.org CAT Core are valid and sensitive to group differences. 👇 #QualityofLife #GivingVoice2Patients #CancerResearch

💡 This afternoon at #ISOQOL, Andreia Moura shared findings on how to improve PROM completion in cancer clinical trials. Key takeaways: reduce questionnaire redundancy, support patients & ensure site staff understands the value of PRO data collection. #GivingVoice2Patients #QualityofLife @eortc.org

📍 #ISOQOL 2026 This morning, Andreia Moura presented findings on @eortc.org item Q168, a single-item measure of cancer treatment burden. Preliminary results suggest the item is clear and well understood by patients across different cancer types. #QualityofLife #GivingVoice2Patients #CancerResearch

🗣️ This morning at #ISOQOL 2026, Lisa Wintner presented a new @eortc.org health-related #QualityofLife questionnaire for renal cell cancer patients. The project identified key patient-relevant concerns and is now progressing through international pre-testing. #GivingVoice2Patients #CancerResearch

We are looking forward to #ISOQOL 2026 in Prague! The @eortc.org #QualityofLife Group will present 16 abstracts (6 oral, 10 poster) showcasing advances in PRO & HRQoL research, paediatric oncology, survivorship and questionnaire development. 🔗 www.eortc.org/blog/2026/10... #GivingVoice2Patients

💬 Putting patients at the heart of cancer research. For #ECRF50, Mila Ogalla Toledo shares her journey into patient advocacy and hopes for the future of cancer care. 👉 Read her story: https://www.eortcresearchfund.org/2026/10/01/putting-patients-at-the-heart-of-cancer-research/

Save the dates for the next @eortc.org #QualityofLife Group meetings! 📅 15-16 April 2027 | Oslo, Norway 📅 30 Sep-1 Oct 2027 | Warsaw, Poland Looking forward to another year of collaboration and scientific exchange. 🔗 qol.eortc.org/events/ #GivingVoice2Patients #QLGmeeting

📢 The call for abstracts for #EORTCSummit 2027 is now open! 🗓️ Submit your abstract by 4 November 2026 and share your research with the clinical cancer research community. We look forward to seeing quality of life research represented at the Summit! 🌻 👇 #GivingVoice2Patients #QualityofLife

📝 An important CSO–EORTC collaboration focused on making patient-reported outcomes more meaningful and useful for treatment decision-making. 👇 @csoncol.bsky.social #GivingVoice2Patients #QualityofLife

👏 That's a wrap on the @eortc.org autumn 2026 #QLGmeeting! Thank you to all participants, speakers and organisers for two days of stimulating discussions, new ideas and collaborations that help drive #QualityofLife research forward. Safe travels and see you in spring 2027! #GivingVoice2Patients

One day after marking the 10th anniversary of #WorldCancerResearchDay in Brussels, the message is clear: progress happens when we work together. We thank everyone who contributed to yesterday's inspiring celebration at EORTC HQ and to advancing cancer research for patients worldwide.

At today’s #WorldCancerResearchDay event, Denis Lacombe, CEO of EORTC: "World Cancer Research Day reminds us that better cancer care is not always about more treatment, but about the right treatment for the right patient, supported by strong academic cancer research."

👏🏼 Room full for the start of the @eortc.org Quality of Life Group autumn meeting today in Zagreb! Looking forward to two days of exchange and collaboration, and to further advancing quality of life research together. #QualityofLife #QLGmeeting #GivingVoice2Patients

📰 The 2026 @eortc.org #QualityofLife Group (QLG) newsletter has arrived! Catch up on the latest QLG research and initiatives, including perspectives on the opportunities and challenges of AI in quality of life research. 🔗 qol.eortc.org/newsletters/ #GivingVoice2Patients #CancerResearch

One week to go until the 10th Anniversary #WorldCancerResearchDay International Event. The speaker lineup is set. Join leading voices from research, healthcare and patient advocacy on 23 September. 🎥 Follow live: www.youtube.com/live/35YcRy-... #AdvancingCancerResearchTogether

Remembering our friend and colleague Prof. Neil Aaronson. As a founding member, former Chair and mentor, Neil helped shape both the science and the spirit of the EORTC Quality of Life Group. His legacy will continue to inspire us for years to come. 💙 www.eortc.org/blog/2026/09...

🗣️ Giving older adults a stronger voice in cancer research. Congratulations to Pierluigi Bonomo and colleagues on this EORTC Older Adult Council and #QualityofLife Group publication, exploring how patient preferences can help shape more patient-centred cancer research. 👇 #GivingVoice2Patients

🌻 Giving cancer survivors a stronger voice in research and care starts with measuring what matters to them. An important @eortc.org Quality of Life Group publication led by Louis Fox, helping advance quality of life assessment in cancer survivorship. 👇 #GivingVoice2Patients #QualityofLife

📢 Final reminder for @eortc.org #QualityofLife (QLG) members: registration for the QLG autumn meeting 2026 in Zagreb (24–25 September) closes on 31 August. 📧 Registration details have been shared by email with members today. 🔗 More information: www.eortc.org/event/eortc-... #QLGmeeting

🎗️ What patients experience matters. This #QualityofLife & Lung Cancer Group study shows that EORTC questionnaires can capture many common patient-reported symptomatic adverse events in #NSCLC. Better cancer care starts by listening to patients. #WorldLungCancerDay #GivingVoice2Patients 👇

🗣️ Giving patients a voice in cancer care. From the EORTC QLQ-C30 to digital and adaptive patient-reported outcome (PRO) measures, this paper in EJC highlights the impact of the @eortc.org #QualityofLife Group and its vision for the future. 🔗 qol.eortc.org/eortc-qlg-ou... #GivingVoice2Patients

📄 New publication from the @eortc.org #QualityofLife Group. The new EORTC QLQ‑VU34 questionnaire was developed to better capture the impact of vulva cancer and its treatment on patients' quality of life. 🔗 www.eortc.org/publications/ #CancerResearch #GivingVoice2Patients

📢 Reminder for @eortc.org #QualityofLife Group (QLG) members: Registration remains open for the EORTC QLG autumn meeting 2026 (24–25 September, Zagreb). Registration details have been shared by email & members are invited to register by 31 August. 🔗 www.eortc.org/event/eortc-... #QLGmeeting

A closer look 👇 The @eortc.org Annual Report 2025 highlights progress across the network—including the #QualityofLife Group’s work to keep quality of life at the heart of cancer research 🌻 Take a look at our contribution & explore the full report: www.eortc.org/annual-report/ #GivingVoice2Patients

The @eortc.org Quality of Life Group (QLG) is pleased to announce that Susanne Singer has been elected Chair‑Elect of the QLG Executive Committee. Susanne will take up her role at the QLG autumn 2026 meeting in Zagreb. More information: qol.eortc.org/susanne-sing... #QualityofLife

🎤 Today at the 10th UK PROMs Research Conference Louis Fox from the @eortc.org #QualityofLife Group is presenting an international effort to improve HRQoL measurement for patients receiving Immune Checkpoint Inhibitors (ICIs). 👉 sheffield.ac.uk/smph/events/... #CancerResearch #GivingVoice2Patients

📣 Registration is now open for the @eortc.org Quality of Life Group (QLG) autumn meeting 2026. 📅 24-25 September 📍 Zagreb, Croatia 📨 Registration link sent to all EORTC QLG members by email today 🔗 More info on programme, venue, etc: www.eortc.org/event/eortc-... #QLGmeeting #QualityofLife

📄 A new @ihieurope.bsky.social factsheet highlights the SISAQOL‑IMI project and its recommendations and tools to improve HRQOL and PRO data in cancer clinical trials. 🔗 Learn more: www.sisaqol.org/2026/06/17/s... #SISAQOL #QualityofLife #GivingVoice2Patients @eortc.org

🎤 #EHA2026 poster highlight A treatment-specific European Organisation for Research and Treatment of Cancer QLG HRQoL module is being developed to better assess #QualityofLife in patients receiving CAR T-cell therapy & T-cell engaging antibodies, with input from patients & healthcare professionals.

📢 Today at #EHA2026 Kyra Michielsen, member of European Organisation for Research and Treatment of Cancer Quality of Life Group, is presenting a poster on advancing health-related quality of life assessment for patients receiving novel immunotherapies. Learn more 👇 #QualityofLife #CancerResearch

📊 An important milestone for quality of life research. This study supports the use of the @eortc.org QLQ‑C30 in adolescents with cancer, strengthening continuity of quality of life assessment across adolescent & adult age groups. www.eortc.org/blog/2026/06... #QualityofLife #GivingVoice2Patients

🗳️ Voting is open for the @eortc.org Quality of Life Group (QLG) Chair-Elect election. Sally Wheelwright and Susanne Singer are standing as candidates. 🗓️ Vote open until 16 June (QLG active members only) More details: qol.eortc.org/eortc-qlg-ex... #EORTC #QualityofLife

📄 New EORTC #QualityofLife Group publication in @eclinicalmed.bsky.social evaluates the contemporary clinical utility and measurement performance of the @eortc.org QLQ‑BM22, a key tool for measuring quality of life in patients with bone metastases. 🔗 www.eortc.org/publications/ #CancerResearch

🎤 Today at #ASCO26: EORTC Quality of Life Group member Vesna Bjelic-Radisic presents new insights on the @eortc.org QLQ‑OV28 update. Advancing how we measure #QualityofLife for patients with #OvarianCancer. 🔗 www.asco.org/abstracts-pr... #GivingVoice2Patients #CancerResearch @ascocancer.bsky.social

New from @eortc.org #QualityofLife Group 📢 This study introduces novel time‑dynamic machine learning models to predict impaired HRQoL in early #BreastCancer, enabling more timely, targeted care — while highlighting the need for fair AI. 👉 www.eortc.org/publications/ #CancerCare @jmirpub.bsky.social

This article highlights #SISAQOL as a truly international public–private partnership, uniting diverse stakeholders to strengthen analysis & interpretation of quality of life data in cancer clinical trials. @eortc.org #QualityofLife Group is proud to be part of this initiative.⬇️ #ClinicalTrialsDay

Clinical trials play a key role in the development and approval of new medicines. EORTC CEO Denis Lacombe explains their purpose and importance in this video. 👇

👏 Save the date: 23–24 March 2027, Brussels (Belgium) Upcoming @eortc.org Summit, a new flagship event aiming to break boundaries in clinical cancer research. More info ⬇️ #EORTCsummit #QualityofLife #CancerResearch #ClinicalTrials #ClinicalTrialsDay

💪 This morning at #ESTRO2026, EORTC Quality of Life Group member Vassilios Vassiliou will present the @eortc.org QLQ-ANL27: the world’s first validated HRQoL questionnaire for people treated with chemoradiotherapy for #AnalCancer. 🔗 www.eortc.org/blog/2026/04... #QualityofLife #GivingVoice2Patients